Skip to content

DISPARITY Study: An Observational Evaluation of Characteristics of Participants in Clinical Studies

An Observational Evaluation of Characteristics of Participants in Clinical

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06486402
Acronym
DISPARITY
Enrollment
5000
Registered
2024-07-03
Start date
2023-03-15
Completion date
2024-12-01
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participation Rate, Patient, Patient Participation

Brief summary

The aim of this study is to evaluate whether females are underrepresented in clinical studies in the Departments of Anaesthesia and Intensive Care, Amsterdam UMC, locations AMC and VUmc. The main outcome is Participation Prevalence Ratio (PPR), which means the representation of female/male patients in a study in relation to their representation in the disease population undergoing surgery. To achieve this, we will use the average proportion of female participants enrolled per study and, in addition, data from the CBS for population benchmarking, determining the proportions of males and females undergoing surgery (elective cardiac and non-cardiac surgery) and the proportions of these populations in an academic hospital.

Interventions

OTHERparticipation rate

participation rate

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* various clinical trials, both falling within and outside the scope of the Medical Research Involving Human Subjects Act * adult patients undergoing various types of medical surgeries.

Exclusion criteria

. studies which excluded or did not equally approach women beforehand

Design outcomes

Primary

MeasureTime frameDescription
Participation rate5 yearNumber of patients participating in a clinical trial

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026